(Q22250970)

Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease

volume

17

0 references

issue

3

0 references

page(s)

307-320

0 references

cites work

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01482.X

Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease

20 April 2017

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01482.X

Review article: the management of severe Crohn's disease

20 April 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

Energy metabolism and substrate oxidation in patients with Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

Reduced bone density in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

Fracture risk is increased in Crohn's disease, but not in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

Vascular complications of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

Hyperhomocysteinemia and prevalence of polymorphisms of homocysteine metabolism-related enzymes in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

Increased levels of homocysteine in patients with Crohn's disease are related to folate levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

Increased prevalence of methylenetetrahydrofolate reductase C677T variant in patients with IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

Microbial translocation in neonates and infants receiving long-term parenteral nutrition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

Gut bacterial translocation during total parenteral nutrition in experimental rats and its countermeasure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

Irreversible intestinal failure, nutrition support, and small bowel transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

Nutritional management of short bowel syndrome in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

Manganese intoxication during total parenteral nutrition: report of two cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

Complications of long-term home total parenteral nutrition: their identification, prevention and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

Remaining small bowel length: association with catheter sepsis in patients receiving home total parenteral nutrition: evidence of bacterial translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

Dietary treatment of irritable bowel syndrome: current evidence and guidelines for future practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

Bran and irritable bowel syndrome: time for reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

Lactose intolerance in active Crohn's disease: clinical value of duodenal lactase analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease. British Society of Gastroenterology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

A randomized, placebo-controlled trial of calcium supplementation for decreased bone density in corticosteroid-using patients with inflammatory bowel disease: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

Prevention and treatment of osteoporosis in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

Methylation and colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

Effects of folate supplementation on two provisional molecular markers of colon cancer: a prospective, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

Corticosteroids in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

Crohn's disease: maintenance of remission by diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

Does adjuvant nutritional support diminish steroid dependency in Crohn disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

Lipid treatment of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

A double-blind, randomized, placebo-controlled trial of essential fatty acid supplementation in the maintenance of remission of ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

Appropriate nutritional support in acute and complicated Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

Nutrition and enterocutaneous fistulas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

Combination of recombinant human growth hormone and glutamine-enriched total parenteral nutrition to surgical patients: effects on circulating amino acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

Double-blind randomized controlled trial of glutamine-enriched polymeric diet in the treatment of active Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

Bacteria as the cause of ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

Probiotics and inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

Effect of sodium butyrate on reactive oxygen species generation by human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

Effects of short-chain fatty acids on the inflamed colonic mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

Treatment of ulcerative colitis with germinated barley foodstuff feeding: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

Germinated barley foodstuff feeding. A novel neutraceutical therapeutic strategy for ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis. Spanish Group for the Study of Crohn's Disease and Ulcerative Colitis (GETECCU)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

Liquid diets for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. American College of Rheumatology Task Force on Osteoporosis Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Nutritional factors in colorectal cancer risk: a case-control study in Majorca

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Short-chain fatty acid in the human colon. Relation to inflammatory bowel diseases and colon cancer.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Red blood cell folate is associated with the development of dysplasia and cancer in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Mechanisms of intestinal failure in Crohn's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Recent developments in home total parenteral nutrition

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Estimated versus measured basal energy requirements in patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Comparison of enteral nutrition and drug treatment in active Crohn's disease. Results of the European Cooperative Crohn's Disease Study. IV.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Meta-analysis of enteral nutrition as a primary treatment of active crohn's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Treatment of active Crohn's disease by exclusion diet: East Anglian multicentre controlled trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Has total bowel rest a beneficial effect in the treatment of Crohn's disease?

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Undernutrition in Crohn's disease: an anthropometric assessment

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

A century of home parenteral nutrition for Crohn's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Therapy of inflammatory bowel disease.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Home parenteral nutrition

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Current results of intestinal transplantation. The International Intestinal Transplant Registry.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Long-chain triglycerides reduce the efficacy of enteral feeds in patients with active Crohn's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Nutritional screening--evaluation and implementation of a simple Nutrition Risk Score.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Effect of folate supplementation on DNA methylation of rectal mucosa in patients with colonic adenomas: correlation with nutrient intake

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Nutritional issues in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Nutrition and inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Inflammatory bowel disease and cancer

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Childhood Crohn's disease and the efficacy of enteral diets

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Germinated barley foodstuffs attenuate colonic mucosal damage and mucosal nuclear factor kappa B activity in a spontaneous colitis model

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Treatments for Crohn's disease that minimise steroid doses are associated with a reduced risk of osteoporosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Treatment of inflammatory bowel disease in childhood

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

The relation between antioxidant status and alterations in fatty acid profile in patients with Crohn disease and controls

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Resting and total energy expenditure in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Dairy sensitivity, lactose malabsorption, and elimination diets in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Elevated diet-induced thermogenesis and lipid oxidation rate in Crohn disease.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Polyunsaturated fatty acids and inflammatory bowel disease.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Total parenteral nutrition: potion or poison?

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Folate intake and carcinogenesis of the colon and rectum

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Alcohol and nutrients in relation to colon cancer in middle-aged adults

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Nutrition in inflammatory bowel disease: impact on disease and therapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

The metabolic impact of active ulcerative colitis. Energy expenditure and nitrogen balance.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

The role of total parenteral nutrition in the management of patients with acute attacks of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Effect of a vegetable-protein-rich polymeric diet treatment on body composition and energy metabolism in inactive Crohn's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Increase of bone mineral density with sodium fluoride in patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Efficacy and tolerability of a low microparticle diet in a double blind, randomized, pilot study in Crohn's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Nutritional therapy in Crohn's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Nutritional supplementation with N-3 fatty acids and antioxidants in patients with Crohn's disease in remission: effects on antioxidant status and fatty acid profile

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Probiotics and inflammatory bowel disease: is there a scientific rationale?

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Risk factors for low bone density in Crohn's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Microsatellite instability in non-neoplastic mucosa of patients with ulcerative colitis: effect of folate supplementation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Micronutrient deficiencies. A major cause of DNA damage

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Elemental diet as primary treatment of acute Crohn's disease: a controlled trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Enteral nutrition in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Osteoporosis in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Controlled trial of bowel rest and nutritional support in the management of Crohn's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Ten years' experience with an elemental diet in the management of Crohn's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Colonic preservation reduces need for parenteral therapy, increases incidence of renal stones, but does not change high prevalence of gall stones in patients with a short bowel

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Increased prevalence of methylenetetrahydrofolate reductase C677T variant in patients with inflammatory bowel disease, and its clinical implications

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

1 reference

7 January 2021

Effects of glutamine supplementation, GH, and IGF-I on glutamine metabolism in critically ill patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Germinated barley foodstuff exhibits different adsorption properties for hydrophilic versus hydrophobic bile acids

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Factors preceding relapse of ulcerative colitis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Glutamine-enriched total parenteral nutrition maintains intestinal interleukin-4 and mucosal immunoglobulin A levels

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Short-term efficacy of enteral nutrition in the treatment of active Crohn's disease: a randomized, controlled trial comparing nutrient formulas

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Evaluation of stress factors and body weight adjustments currently used to estimate energy expenditure in hospitalized patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

What is subjective global assessment of nutritional status?

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Dry beriberi: unusual complication of prolonged parenteral nutrition

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Glutamine-supplemented parenteral nutrition improves gut mucosa integrity and function in endotoxemic rats

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

How effective is enteral nutrition in inducing clinical remission in active Crohn's disease? A meta-analysis of the randomized clinical trials

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Effect of long-term oral glutamine supplements on small intestinal permeability in patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Rapid development of severe copper deficiency in a patient with Crohn's disease receiving parenteral nutrition

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Enteral nutrition in inflammatory bowel disease of childhood

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Effects of germinated barley foodstuff on microflora and short chain fatty acid production in dextran sulfate sodium-induced colitis in rats

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Wernicke encephalopathy and beriberi during total parenteral nutrition attributable to multivitamin infusion shortage

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Longitudinal study of cortical bone loss in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Defined-formula diets versus steroids in the treatment of active Crohn's disease: a meta-analysis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multicenter trial. Study Group Members (German Crohn's Disease Study Group).

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021

The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01482.X

7 January 2021